Ameritas Investment Partners’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-6,565
| Closed | -$118K | – | 3113 |
|
|
2020
Q2 | $118K | Hold |
6,565
| – | – | 0.01% | 1315 |
|
|
2020
Q1 | $47K | Hold |
6,565
| – | – | ﹤0.01% | 1700 |
|
|
2019
Q4 | $157K | Buy |
6,565
+351
| +6% | +$9.68K | 0.01% | 1240 |
|
|
2019
Q3 | $167K | Buy |
6,214
+788
| +15% | +$22.1K | 0.01% | 1159 |
|
|
2019
Q2 | $147K | Hold |
5,426
| – | – | 0.01% | 1255 |
|
|
2019
Q1 | $188K | Hold |
5,426
| – | – | 0.01% | 1087 |
|
|
2018
Q4 | $106K | Hold |
5,426
| – | – | 0.01% | 1340 |
|
|
2018
Q3 | $144K | Buy |
5,426
+215
| +4% | +$7.02K | 0.01% | 1304 |
|
|
2018
Q2 | $197K | Buy |
5,211
+507
| +11% | +$19.4K | 0.01% | 1077 |
|
|
2018
Q1 | $154K | Hold |
4,704
| – | – | 0.01% | 1224 |
|
|
2017
Q4 | $229K | Buy |
4,704
+450
| +11% | +$22.8K | 0.01% | 1020 |
|
|
2017
Q3 | $269K | Hold |
4,254
| – | – | 0.01% | 920 |
|
|
2017
Q2 | $239K | Hold |
4,254
| – | – | 0.01% | 973 |
|
|
2017
Q1 | $167K | Buy |
+4,254
| New | +$135K | 0.01% | 1157 |
|
Ameritas Investment Partners's PTLA Position: Q3 2020 in Review
Ameritas Investment Partners sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 6,565 shares — an estimated $118K sold.
Ameritas Investment Partners first reported a position in PTLA in Q1 2017 and held it in 14 quarters. The position peaked at $269K in Q3 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Ameritas Investment Partners reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Ameritas Investment Partners sold 6,565 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $118K.
- Ameritas Investment Partners first reported a position in Portola Pharmaceuticals, Inc. in Q1 2017 and held it in 14 quarters.
- Ameritas Investment Partners's Portola Pharmaceuticals, Inc. position peaked at $269K in Q3 2017.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Ameritas Investment Partners's 13F filing for Q3 2020, filed 13 Nov 2020.